WallStreetZenWallStreetZen

NYSE: BHVN
Biohaven Ltd Stock

$50.36-2.07 (-3.95%)
Updated Nov 12, 2024
BHVN Price
$50.36
Fair Value Price
N/A
Market Cap
$4.76B
52 Week Low
$26.80
52 Week High
$62.21
P/E
-5.47x
P/B
12.41x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$746.61M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.52
Operating Cash Flow
-$480M
Beta
1.64
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

BHVN Overview

Biohaven Pharmaceutical Holding Company Ltd. is a clinical-stage biopharmaceutical company targeting neurological diseases, including rare disorders. Its pipeline includes BHV3000-301, BHV3000-302, BHV3000-303, and others. Biohaven Pharmaceutical has a collaboration agreement with Thirty Madison, Inc. d/b/a Cove to facilitate telemedicine evaluations for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, CT.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BHVN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BHVN is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BHVN is poor value based on its book value relative to its share price (12.41x), compared to the US Biotechnology industry average (5.72x)
P/B vs Industry Valuation
BHVN is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BHVN due diligence checks available for Premium users.

Be the first to know about important BHVN news, forecast changes, insider trades & much more!

BHVN News

Valuation

BHVN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-5.47x
Industry
-129.54x
Market
27.21x

BHVN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
12.41x
Industry
5.72x
BHVN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BHVN's financial health

Profit margin

Revenue
$0.0
Net Income
-$319.8M
Profit Margin
0%
BHVN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$582.6M
Liabilities
$198.9M
Debt to equity
0.52
BHVN's short-term assets ($511.27M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BHVN's short-term assets ($511.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BHVN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$167.8M
Investing
-$97.9M
Financing
$321.1M
BHVN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BHVN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BHVN$4.76B-3.95%-5.47x12.41x
AXSM$4.78B+9.35%-15.17x46.43x
TGTX$4.81B+0.55%-343.44x25.04x
CRNX$4.70B-2.05%-15.63x5.66x
BBIO$4.63B-5.74%-9.36x-4.24x

Biohaven Stock FAQ

What is Biohaven's quote symbol?

(NYSE: BHVN) Biohaven trades on the NYSE under the ticker symbol BHVN. Biohaven stock quotes can also be displayed as NYSE: BHVN.

If you're new to stock investing, here's how to buy Biohaven stock.

What is the 52 week high and low for Biohaven (NYSE: BHVN)?

(NYSE: BHVN) Biohaven's 52-week high was $62.21, and its 52-week low was $26.80. It is currently -19.05% from its 52-week high and 87.91% from its 52-week low.

How much is Biohaven stock worth today?

(NYSE: BHVN) Biohaven currently has 94,542,253 outstanding shares. With Biohaven stock trading at $50.36 per share, the total value of Biohaven stock (market capitalization) is $4.76B.

Biohaven stock was originally listed at a price of $8.30 in Oct 4, 2022. If you had invested in Biohaven stock at $8.30, your return over the last 2 years would have been 506.75%, for an annualized return of 146.32% (not including any dividends or dividend reinvestments).

How much is Biohaven's stock price per share?

(NYSE: BHVN) Biohaven stock price per share is $50.36 today (as of Nov 12, 2024).

What is Biohaven's Market Cap?

(NYSE: BHVN) Biohaven's market cap is $4.76B, as of Nov 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biohaven's market cap is calculated by multiplying BHVN's current stock price of $50.36 by BHVN's total outstanding shares of 94,542,253.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.